| DAIC

May 20, 2022 — Results from a retrospective analysis reveal significantly higher mortality rates for low-income residents hospitalized with ST-elevation myocardial infarction (STEMI) when compared to higher-income residents. The findings were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

Read more about New Study Finds Low-income Patients at Higher Risk of Death After Heart Attack

May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin monotherapy beyond 12 months after PCI in high-risk patients during the chronic maintenance period.

Read more about Long-term Use of Clopidogrel Monotherapy Associated with Lower Patient Risk Compared to Aspirin Motherapy

May 20, 2022 — Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented as late-breaking clinical research at the Society

Read more about No-implant Interatrial Shunt Device to Treat Heart Failure Patients Reveals Promising Multi-center Clinical Data

May 20, 2022 — A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion Intervention), an international multi-center registry of chronic total occlusion (CTO)

Read more about International Chronic Total Occlusion Percutaneous Coronary Intervention Registry Finds Increasing Procedural Success

May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD) study were presented as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

Read more about New Longterm Data of Paclitaxel Devices Continues to Show No Increased Mortality Compared to Non-drug Coated Devices

May 20, 2022 — Abbott announced two late-breaking data presentations highlighting both TriClip, a first-of-its kind minimally invasive tricuspid heart valve repair device, and Navitor, the company's latest-generation

Read more about New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies

May 19, 2022 — A study of 1-year outcomes in the largest cohort to date of Harmony transcatheter pulmonary valve (TPV) patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR) was presented today as late-breaking clinical research a

Read more about First Intermediate to Long-term Study of the Harmony Transcatheter Pulmonary Valve System Validates Safety and Efficacy

May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug-coated balloon (DCB) to percutaneous translumi

Read more about Disrupt PAD III Trial Demonstrates Safety and Effectiveness of Intravascular Lithotripsy for Peripheral Artery Calcification

May 19, 2022 — The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

Read more about International COVID-19 Registry Finds Significant Increased Risk of In-hospital Mortality for STEMI Patients with COVID-19 Compared to Pre-pandemic

May 19, 2022 — Initial findings from the Distal versus Proximal Radial Artery Access for Cardiac Catheterization and Intervention (DIPRA) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

Read more about Novel Distal Radial Access for Cardiac Catheterization Shown as a Safe Strategy Compared to Conventional Radial Access

Subscribe to